Technische Universität Dresden

University / College


Location: Dresden, Germany (DE) DE

ISNI: 0000000121117257

ROR: https://ror.org/042aqky30

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Highly accessible and dense surface single metal FeN4 active sites for promoting the oxygen reduction reaction (2022) Chen G, An Y, Liu S, Sun F, Qi H, Wu H, He Y, et al. Journal article Atomic Sn–enabled high-utilization, large-capacity, and long-life Na anode (2022) Xu F, Qu C, Lu Q, Meng J, Zhang X, Xu X, Qiu Y, et al. Journal article Band transport by large Fröhlich polarons in MXenes (2022) Zheng W, Sun B, Li D, Gali SM, Zhang H, Fu S, Di Virgilio L, et al. Journal article Emerging Internet of Things driven carbon nanotubes-based devices (2022) Zhang S, Pang J, Li Y, Yang F, Gemming T, Wang K, Wang X, et al. Journal article, Review article Real-Time Monitoring of Blood Parameters in the Intensive Care Unit: State-of-the-Art and Perspectives (2022) Bockholt R, Paschke S, Heubner L, Ibarlucea B, Laupp A, Janicijevic Z, Klinghammer S, et al. Journal article, Review article Microfluidic Microcirculation Mimetic as a Tool for the Study of Rheological Characteristics of Red Blood Cells in Patients with Sickle Cell Anemia (2022) Asuquo MI, Effa E, Gbotosho O, Otu A, Toepfner N, Ameh S, Bhayankaram SP, et al. Journal article The Architecture of a Feasibility Query Portal for Distributed COVID-19 Fast Healthcare Interoperability Resources (FHIR) Patient Data Repositories: Design and Implementation Study (2022) Gründner J, Deppenwiese N, Folz M, Koehler T, Kroll B, Prokosch HU, Rosenau L, et al. Journal article Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant treatment (2022) Marme F, Hanusch C, Furlanetto J, Morris P, Link T, Denkert C, Fasching P, et al. Conference contribution Patient quality of life (QoL) from the GeparX trial on the addition of denosumab (Dmab) added to two different nab-paclitaxel (nP) regimens as neoadjuvant chemotherapy (NACT) in primary breast cancer (BC) (2022) Reinisch M, Blohmer JU, Link T, Just M, Untch M, Stoetzer O, Fasching P, et al. Conference contribution Effect of high-energy electrons on the thermal, mechanical and fire safety properties of fire-retarded polypropylene nanocomposites (2022) Xiao D, Gohs U, Wagenknecht U, Voit B, Xiao XQ, Peng XF, Wang DY Journal article